AI-driven anticancer peptide de novo design
Developing AI methods to generate novel anticancer peptides while jointly considering activity, selectivity, safety, and developability.
Research projects in multimodal AI, medical imaging, and protein modelling.
Developing AI methods to generate novel anticancer peptides while jointly considering activity, selectivity, safety, and developability.
Data-efficient multimodal learning for fMRI-based drug-response prediction.
Learning from genetics, biomarkers, environment, and clinical examinations to study Parkinson's disease mechanisms and progression.
Studying protein AI across connected biological states through MuSProt, with MusBench for evaluating how models transfer knowledge and remain consistent between states.
An agentic closed-loop laboratory that generates, screens, verifies, and iteratively improves selective and stable metal-binding proteins.